Cargando…
Topical Imiquimod Treatment of Lentigo Maligna
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasive melanoma if left untreated. It mainly occurs on sun-exposed areas of elderly patients. The lesions can be large and conventional surgery can be difficult, particularly on the face. Recent reports in...
Autores principales: | Ventura, F., Rocha, J., Fernandes, J.C., Pardal, F., Brito, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895216/ https://www.ncbi.nlm.nih.gov/pubmed/20652120 http://dx.doi.org/10.1159/000249151 |
Ejemplares similares
-
Repigmentation of gray hairs with lentigo maligna and response to topical imiquimod
por: Lackey, Alexandra E., et al.
Publicado: (2019) -
Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature
por: Vaienti, Silvia, et al.
Publicado: (2023) -
Observational Study of Topical Imiquimod Immunotherapy in the Treatment of Difficult Lentigo Maligna
por: Craythorne, E.E., et al.
Publicado: (2008) -
Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream
por: Kim, Na Hee, et al.
Publicado: (2018) -
Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
por: Rovesti, Miriam, et al.
Publicado: (2021)